Sima Ghafari

Nob Hill Therapeutics mission is to commercialize the first-of-its-kind dry powder nebulizer (DryNebTM ) inhalation drug delivery platform. NHT is focused on creating effective inhalation therapies to address lower respiratory tract infections (the 5th leading overall cause of death worldwide) and other deadly lung diseases.

ORNA is a cyber incident response and case management platform for small teams that detects cyberattacks and uses AI to guide response, reporting, compliance and prevention efforts through an innovative real-time collaborative environment.

Reglagene is a therapeutics company that leverages its expertise in the design and development of brain penetrant medicines to create breakthrough therapies for the safe and effective treatment of brain diseases.

We are a physician- and scientist-founded healthcare venture capital group, investing broadly across sectors at the Seed & Series A stages. MEDA Ventures rests on the investment activities of its legacy Fund & broader investment portfolio (22 companies, 2 exits, 0 shutdowns since 2019, as of 6/2024).

TCA Venture Group Orange County (TCA OC) is part of TCA Venture Group (TCA VG), one of the largest angel investor groups in the U.S. TCA OC has been fueling the growth of innovative companies and entrepreneurs in Orange County and across the US and Canada since 1997. TCA OC identifies, mentors and funds early stage companies to help get their products to market. TCA OC members devote their time, expertise and capital to help companies grow and succeed. TCA Venture Group members number over 400 and consist of experienced CEOs, senior executives, current and former entrepreneurs, venture capitalists and other professionals. Members not only invest but frequently serve on boards and assist companies with relationships, strategy, supply chain, team building and additional fundraising. TCA VG has an outstanding deal flow of opportunities and a simplified yet organized process for screening and completing due diligence.

We are Makani Science, an innovative company creating a small wireless wearable respiratory monitors using innovative stretchable electronic sensors. We are on a path to develop the worlds first Continuous Respiration Monitor.

Elio Partners is a group of experienced professionals with broad real-world experience in evaluating early-stage companies for investor groups looking to assess potential investment opportunities. Elio Partners can use their success in evaluating and managing companies in difficult business situations. There is a need to obtain the “best” information available at the time of decision whether to invest or not. While the very nature of the risk of investing in companies at an early stage in their development is the lack of meaningful data and track record, there are aspects of the investment and the surrounding business environment that could be discoverable and analyzed with the right team and tools Elio Partners is the Due Diligence Company that has the experience to assist investors at this crucial decision point. For more information, take a look at our website at www.elio-partners.com or contact us at contact@elio-partners.com or call us at 949-XXX-XXXX to set up an appointment with one of

Nob Hill Therapeutics mission is to commercialize the first-of-its-kind dry powder nebulizer (DryNebTM ) inhalation drug delivery platform. NHT is focused on creating effective inhalation therapies to address lower respiratory tract infections (the 5th leading overall cause of death worldwide) and other deadly lung diseases.

ORNA is a cyber incident response and case management platform for small teams that detects cyberattacks and uses AI to guide response, reporting, compliance and prevention efforts through an innovative real-time collaborative environment.

Reglagene is a therapeutics company that leverages its expertise in the design and development of brain penetrant medicines to create breakthrough therapies for the safe and effective treatment of brain diseases.